Montrucchio, G., Sales, G., Rumbolo, F., Palmesino, F., Fanelli, V., Urbino, R., . . . Brazzi, L. (2021). Effectiveness of mid-regional pro-adrenomedullin (MR-proADM) as prognostic marker in COVID-19 critically ill patients: An observational prospective study. PLoS One.
Stile di citazione ChicagoMontrucchio, Giorgia, Gabriele Sales, Francesca Rumbolo, Filippo Palmesino, Vito Fanelli, Rosario Urbino, Claudia Filippini, Giulio Mengozzi, e Luca Brazzi. "Effectiveness of Mid-regional Pro-adrenomedullin (MR-proADM) As Prognostic Marker in COVID-19 Critically Ill Patients: An Observational Prospective Study." PLoS One 2021.
Citazione MLAMontrucchio, Giorgia, et al. "Effectiveness of Mid-regional Pro-adrenomedullin (MR-proADM) As Prognostic Marker in COVID-19 Critically Ill Patients: An Observational Prospective Study." PLoS One 2021.